Banque Cantonale Vaudoise Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Banque Cantonale Vaudoise purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 7,216 shares of the biotechnology company’s stock, valued at approximately $2,123,000.

Other institutional investors have also modified their holdings of the company. ICA Group Wealth Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $26,000. Blue Trust Inc. grew its stake in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the last quarter. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise in the first quarter worth $31,000. First PREMIER Bank bought a new stake in Axon Enterprise in the first quarter valued at $33,000. Finally, Blue Bell Private Wealth Management LLC acquired a new position in shares of Axon Enterprise during the first quarter valued at $41,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Bank of America started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Jefferies Financial Group began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price target for the company. Northland Securities lifted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Barclays upped their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Finally, JMP Securities reissued a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $358.08.

Insider Transactions at Axon Enterprise

In related news, Director Matthew R. Mcbrady sold 2,000 shares of the company’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Matthew R. Mcbrady sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares in the company, valued at $1,783,916.72. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the transaction, the director now owns 7,379 shares in the company, valued at approximately $2,752,588.37. The disclosure for this sale can be found here. Insiders sold a total of 152,750 shares of company stock valued at $56,105,818 over the last quarter. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 0.8 %

NASDAQ AXON traded up $2.97 on Friday, hitting $364.97. 454,912 shares of the company were exchanged, compared to its average volume of 518,717. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $378.89. The company’s 50 day moving average price is $325.12 and its 200-day moving average price is $307.81. The firm has a market capitalization of $27.54 billion, a P/E ratio of 106.72, a price-to-earnings-growth ratio of 9.66 and a beta of 0.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the firm earned $0.80 EPS. The firm’s quarterly revenue was up 34.5% on a year-over-year basis. Analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.